0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-opioid Pain Patches Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-25F9493
Home | Market Reports | Health| Pharmacy
Global Non opioid Pain Patches Market Insights and Forecast to 2028
BUY CHAPTERS

Global Non-opioid Pain Patches Market Research Report 2025

Code: QYRE-Auto-25F9493
Report
August 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-opioid Pain Patches Market Size

The global market for Non-opioid Pain Patches was valued at US$ 684 million in the year 2024 and is projected to reach a revised size of US$ 816 million by 2031, growing at a CAGR of 2.6% during the forecast period.

Non-opioid Pain Patches Market

Non-opioid Pain Patches Market

North American market for Non-opioid Pain Patches is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non-opioid Pain Patches is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Non-opioid Pain Patches include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical, Teikoku Seiyaku, IBSA Institut Biochimque SA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-opioid Pain Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Pain Patches.
The Non-opioid Pain Patches market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-opioid Pain Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-opioid Pain Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-opioid Pain Patches Market Report

Report Metric Details
Report Name Non-opioid Pain Patches Market
Accounted market size in year US$ 684 million
Forecasted market size in 2031 US$ 816 million
CAGR 2.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Lidocaine Patch
  • Diclofenac Patch
  • Methyl Salicylate Patch
  • Capsaicin Patch
  • Ketoprofen Patch
  • Others
Segment by Application
  • Hospital Pharmacies
  • Independent Pharmacies & Drug Stores
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical, Teikoku Seiyaku, IBSA Institut Biochimque SA, Acorda Therapeutics, Allergan PLC, Endo International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-opioid Pain Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-opioid Pain Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Non-opioid Pain Patches Market growing?

Ans: The Non-opioid Pain Patches Market witnessing a CAGR of 2.6% during the forecast period 2025-2031.

What is the Non-opioid Pain Patches Market size in 2031?

Ans: The Non-opioid Pain Patches Market size in 2031 will be US$ 816 million.

Who are the main players in the Non-opioid Pain Patches Market report?

Ans: The main players in the Non-opioid Pain Patches Market are Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical, Teikoku Seiyaku, IBSA Institut Biochimque SA, Acorda Therapeutics, Allergan PLC, Endo International

What are the Application segmentation covered in the Non-opioid Pain Patches Market report?

Ans: The Applications covered in the Non-opioid Pain Patches Market report are Hospital Pharmacies, Independent Pharmacies & Drug Stores, Online Pharmacies

What are the Type segmentation covered in the Non-opioid Pain Patches Market report?

Ans: The Types covered in the Non-opioid Pain Patches Market report are Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch, Capsaicin Patch, Ketoprofen Patch, Others

1 Non-opioid Pain Patches Market Overview
1.1 Product Definition
1.2 Non-opioid Pain Patches by Type
1.2.1 Global Non-opioid Pain Patches Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lidocaine Patch
1.2.3 Diclofenac Patch
1.2.4 Methyl Salicylate Patch
1.2.5 Capsaicin Patch
1.2.6 Ketoprofen Patch
1.2.7 Others
1.3 Non-opioid Pain Patches by Application
1.3.1 Global Non-opioid Pain Patches Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Independent Pharmacies & Drug Stores
1.3.4 Online Pharmacies
1.4 Global Non-opioid Pain Patches Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Pain Patches Revenue 2020-2031
1.4.2 Global Non-opioid Pain Patches Sales 2020-2031
1.4.3 Global Non-opioid Pain Patches Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-opioid Pain Patches Market Competition by Manufacturers
2.1 Global Non-opioid Pain Patches Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-opioid Pain Patches Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-opioid Pain Patches Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-opioid Pain Patches, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-opioid Pain Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-opioid Pain Patches, Product Type & Application
2.7 Global Key Manufacturers of Non-opioid Pain Patches, Date of Enter into This Industry
2.8 Global Non-opioid Pain Patches Market Competitive Situation and Trends
2.8.1 Global Non-opioid Pain Patches Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-opioid Pain Patches Players Market Share by Revenue
2.8.3 Global Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-opioid Pain Patches Market Scenario by Region
3.1 Global Non-opioid Pain Patches Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-opioid Pain Patches Sales by Region: 2020-2031
3.2.1 Global Non-opioid Pain Patches Sales by Region: 2020-2025
3.2.2 Global Non-opioid Pain Patches Sales by Region: 2026-2031
3.3 Global Non-opioid Pain Patches Revenue by Region: 2020-2031
3.3.1 Global Non-opioid Pain Patches Revenue by Region: 2020-2025
3.3.2 Global Non-opioid Pain Patches Revenue by Region: 2026-2031
3.4 North America Non-opioid Pain Patches Market Facts & Figures by Country
3.4.1 North America Non-opioid Pain Patches Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-opioid Pain Patches Sales by Country (2020-2031)
3.4.3 North America Non-opioid Pain Patches Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-opioid Pain Patches Market Facts & Figures by Country
3.5.1 Europe Non-opioid Pain Patches Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-opioid Pain Patches Sales by Country (2020-2031)
3.5.3 Europe Non-opioid Pain Patches Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-opioid Pain Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Non-opioid Pain Patches Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-opioid Pain Patches Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-opioid Pain Patches Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-opioid Pain Patches Market Facts & Figures by Country
3.7.1 Latin America Non-opioid Pain Patches Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-opioid Pain Patches Sales by Country (2020-2031)
3.7.3 Latin America Non-opioid Pain Patches Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-opioid Pain Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-opioid Pain Patches Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-opioid Pain Patches Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-opioid Pain Patches Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-opioid Pain Patches Sales by Type (2020-2031)
4.1.1 Global Non-opioid Pain Patches Sales by Type (2020-2025)
4.1.2 Global Non-opioid Pain Patches Sales by Type (2026-2031)
4.1.3 Global Non-opioid Pain Patches Sales Market Share by Type (2020-2031)
4.2 Global Non-opioid Pain Patches Revenue by Type (2020-2031)
4.2.1 Global Non-opioid Pain Patches Revenue by Type (2020-2025)
4.2.2 Global Non-opioid Pain Patches Revenue by Type (2026-2031)
4.2.3 Global Non-opioid Pain Patches Revenue Market Share by Type (2020-2031)
4.3 Global Non-opioid Pain Patches Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-opioid Pain Patches Sales by Application (2020-2031)
5.1.1 Global Non-opioid Pain Patches Sales by Application (2020-2025)
5.1.2 Global Non-opioid Pain Patches Sales by Application (2026-2031)
5.1.3 Global Non-opioid Pain Patches Sales Market Share by Application (2020-2031)
5.2 Global Non-opioid Pain Patches Revenue by Application (2020-2031)
5.2.1 Global Non-opioid Pain Patches Revenue by Application (2020-2025)
5.2.2 Global Non-opioid Pain Patches Revenue by Application (2026-2031)
5.2.3 Global Non-opioid Pain Patches Revenue Market Share by Application (2020-2031)
5.3 Global Non-opioid Pain Patches Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Non-opioid Pain Patches Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Non-opioid Pain Patches Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Non-opioid Pain Patches Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Company Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis AG Non-opioid Pain Patches Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Mylan N.V.
6.5.1 Mylan N.V. Company Information
6.5.2 Mylan N.V. Description and Business Overview
6.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan N.V. Non-opioid Pain Patches Product Portfolio
6.5.5 Mylan N.V. Recent Developments/Updates
6.6 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Company Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Product Portfolio
6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.7 Hisamitsu Pharmaceutical
6.7.1 Hisamitsu Pharmaceutical Company Information
6.7.2 Hisamitsu Pharmaceutical Description and Business Overview
6.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Portfolio
6.7.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.8 TEH SENG Pharmaceutical
6.8.1 TEH SENG Pharmaceutical Company Information
6.8.2 TEH SENG Pharmaceutical Description and Business Overview
6.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Product Portfolio
6.8.5 TEH SENG Pharmaceutical Recent Developments/Updates
6.9 Teikoku Seiyaku
6.9.1 Teikoku Seiyaku Company Information
6.9.2 Teikoku Seiyaku Description and Business Overview
6.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teikoku Seiyaku Non-opioid Pain Patches Product Portfolio
6.9.5 Teikoku Seiyaku Recent Developments/Updates
6.10 IBSA Institut Biochimque SA
6.10.1 IBSA Institut Biochimque SA Company Information
6.10.2 IBSA Institut Biochimque SA Description and Business Overview
6.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Product Portfolio
6.10.5 IBSA Institut Biochimque SA Recent Developments/Updates
6.11 Acorda Therapeutics
6.11.1 Acorda Therapeutics Company Information
6.11.2 Acorda Therapeutics Description and Business Overview
6.11.3 Acorda Therapeutics Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Acorda Therapeutics Non-opioid Pain Patches Product Portfolio
6.11.5 Acorda Therapeutics Recent Developments/Updates
6.12 Allergan PLC
6.12.1 Allergan PLC Company Information
6.12.2 Allergan PLC Description and Business Overview
6.12.3 Allergan PLC Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Allergan PLC Non-opioid Pain Patches Product Portfolio
6.12.5 Allergan PLC Recent Developments/Updates
6.13 Endo International
6.13.1 Endo International Company Information
6.13.2 Endo International Description and Business Overview
6.13.3 Endo International Non-opioid Pain Patches Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Endo International Non-opioid Pain Patches Product Portfolio
6.13.5 Endo International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-opioid Pain Patches Industry Chain Analysis
7.2 Non-opioid Pain Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-opioid Pain Patches Production Mode & Process Analysis
7.4 Non-opioid Pain Patches Sales and Marketing
7.4.1 Non-opioid Pain Patches Sales Channels
7.4.2 Non-opioid Pain Patches Distributors
7.5 Non-opioid Pain Patches Customer Analysis
8 Non-opioid Pain Patches Market Dynamics
8.1 Non-opioid Pain Patches Industry Trends
8.2 Non-opioid Pain Patches Market Drivers
8.3 Non-opioid Pain Patches Market Challenges
8.4 Non-opioid Pain Patches Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Non-opioid Pain Patches Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Non-opioid Pain Patches Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Non-opioid Pain Patches Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Non-opioid Pain Patches Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Non-opioid Pain Patches Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Non-opioid Pain Patches Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Non-opioid Pain Patches Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Non-opioid Pain Patches Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Non-opioid Pain Patches, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-opioid Pain Patches, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-opioid Pain Patches, Product Type & Application
 Table 12. Global Key Manufacturers of Non-opioid Pain Patches, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-opioid Pain Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Patches as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-opioid Pain Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Non-opioid Pain Patches Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Non-opioid Pain Patches Sales Market Share by Region (2020-2025)
 Table 19. Global Non-opioid Pain Patches Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Non-opioid Pain Patches Sales Market Share by Region (2026-2031)
 Table 21. Global Non-opioid Pain Patches Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Non-opioid Pain Patches Revenue Market Share by Region (2020-2025)
 Table 23. Global Non-opioid Pain Patches Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Non-opioid Pain Patches Revenue Market Share by Region (2026-2031)
 Table 25. North America Non-opioid Pain Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Non-opioid Pain Patches Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Non-opioid Pain Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Non-opioid Pain Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Non-opioid Pain Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Non-opioid Pain Patches Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Non-opioid Pain Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Non-opioid Pain Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Non-opioid Pain Patches Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Non-opioid Pain Patches Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Non-opioid Pain Patches Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Non-opioid Pain Patches Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Non-opioid Pain Patches Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-opioid Pain Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Non-opioid Pain Patches Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Non-opioid Pain Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Non-opioid Pain Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Non-opioid Pain Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Non-opioid Pain Patches Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Non-opioid Pain Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Non-opioid Pain Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Non-opioid Pain Patches Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Non-opioid Pain Patches Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
 Table 53. Global Non-opioid Pain Patches Sales Market Share by Type (2026-2031)
 Table 54. Global Non-opioid Pain Patches Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Non-opioid Pain Patches Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Non-opioid Pain Patches Revenue Market Share by Type (2020-2025)
 Table 57. Global Non-opioid Pain Patches Revenue Market Share by Type (2026-2031)
 Table 58. Global Non-opioid Pain Patches Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Non-opioid Pain Patches Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Non-opioid Pain Patches Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Non-opioid Pain Patches Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Non-opioid Pain Patches Sales Market Share by Application (2020-2025)
 Table 63. Global Non-opioid Pain Patches Sales Market Share by Application (2026-2031)
 Table 64. Global Non-opioid Pain Patches Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Non-opioid Pain Patches Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Non-opioid Pain Patches Revenue Market Share by Application (2020-2025)
 Table 67. Global Non-opioid Pain Patches Revenue Market Share by Application (2026-2031)
 Table 68. Global Non-opioid Pain Patches Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Non-opioid Pain Patches Price (USD/Pcs) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Pfizer Non-opioid Pain Patches Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Non-opioid Pain Patches Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Non-opioid Pain Patches Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Novartis AG Company Information
 Table 86. Novartis AG Description and Business Overview
 Table 87. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Novartis AG Non-opioid Pain Patches Product
 Table 89. Novartis AG Recent Developments/Updates
 Table 90. Mylan N.V. Company Information
 Table 91. Mylan N.V. Description and Business Overview
 Table 92. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Mylan N.V. Non-opioid Pain Patches Product
 Table 94. Mylan N.V. Recent Developments/Updates
 Table 95. Teva Pharmaceutical Industries Company Information
 Table 96. Teva Pharmaceutical Industries Description and Business Overview
 Table 97. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Teva Pharmaceutical Industries Non-opioid Pain Patches Product
 Table 99. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 100. Hisamitsu Pharmaceutical Company Information
 Table 101. Hisamitsu Pharmaceutical Description and Business Overview
 Table 102. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Hisamitsu Pharmaceutical Non-opioid Pain Patches Product
 Table 104. Hisamitsu Pharmaceutical Recent Developments/Updates
 Table 105. TEH SENG Pharmaceutical Company Information
 Table 106. TEH SENG Pharmaceutical Description and Business Overview
 Table 107. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. TEH SENG Pharmaceutical Non-opioid Pain Patches Product
 Table 109. TEH SENG Pharmaceutical Recent Developments/Updates
 Table 110. Teikoku Seiyaku Company Information
 Table 111. Teikoku Seiyaku Description and Business Overview
 Table 112. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Teikoku Seiyaku Non-opioid Pain Patches Product
 Table 114. Teikoku Seiyaku Recent Developments/Updates
 Table 115. IBSA Institut Biochimque SA Company Information
 Table 116. IBSA Institut Biochimque SA Description and Business Overview
 Table 117. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. IBSA Institut Biochimque SA Non-opioid Pain Patches Product
 Table 119. IBSA Institut Biochimque SA Recent Developments/Updates
 Table 120. Acorda Therapeutics Company Information
 Table 121. Acorda Therapeutics Description and Business Overview
 Table 122. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Acorda Therapeutics Non-opioid Pain Patches Product
 Table 124. Acorda Therapeutics Recent Developments/Updates
 Table 125. Allergan PLC Company Information
 Table 126. Allergan PLC Description and Business Overview
 Table 127. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Allergan PLC Non-opioid Pain Patches Product
 Table 129. Allergan PLC Recent Developments/Updates
 Table 130. Endo International Company Information
 Table 131. Endo International Description and Business Overview
 Table 132. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Endo International Non-opioid Pain Patches Product
 Table 134. Endo International Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Non-opioid Pain Patches Distributors List
 Table 138. Non-opioid Pain Patches Customers List
 Table 139. Non-opioid Pain Patches Market Trends
 Table 140. Non-opioid Pain Patches Market Drivers
 Table 141. Non-opioid Pain Patches Market Challenges
 Table 142. Non-opioid Pain Patches Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-opioid Pain Patches
 Figure 2. Global Non-opioid Pain Patches Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-opioid Pain Patches Market Share by Type: 2024 & 2031
 Figure 4. Lidocaine Patch Product Picture
 Figure 5. Diclofenac Patch Product Picture
 Figure 6. Methyl Salicylate Patch Product Picture
 Figure 7. Capsaicin Patch Product Picture
 Figure 8. Ketoprofen Patch Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Non-opioid Pain Patches Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Non-opioid Pain Patches Market Share by Application: 2024 & 2031
 Figure 12. Hospital Pharmacies
 Figure 13. Independent Pharmacies & Drug Stores
 Figure 14. Online Pharmacies
 Figure 15. Global Non-opioid Pain Patches Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Non-opioid Pain Patches Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Non-opioid Pain Patches Sales (2020-2031) & (K Pcs)
 Figure 18. Global Non-opioid Pain Patches Average Price (USD/Pcs) & (2020-2031)
 Figure 19. Non-opioid Pain Patches Report Years Considered
 Figure 20. Non-opioid Pain Patches Sales Share by Manufacturers in 2024
 Figure 21. Global Non-opioid Pain Patches Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Non-opioid Pain Patches Players: Market Share by Revenue in Non-opioid Pain Patches in 2024
 Figure 23. Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Non-opioid Pain Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Non-opioid Pain Patches Sales Market Share by Country (2020-2031)
 Figure 26. North America Non-opioid Pain Patches Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Non-opioid Pain Patches Sales Market Share by Country (2020-2031)
 Figure 30. Europe Non-opioid Pain Patches Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Non-opioid Pain Patches Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Non-opioid Pain Patches Revenue Market Share by Region (2020-2031)
 Figure 38. China Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Non-opioid Pain Patches Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Non-opioid Pain Patches Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Non-opioid Pain Patches Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Non-opioid Pain Patches Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. U.A.E Non-opioid Pain Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Non-opioid Pain Patches by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Non-opioid Pain Patches by Type (2020-2031)
 Figure 60. Global Non-opioid Pain Patches Price (USD/Pcs) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Non-opioid Pain Patches by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Non-opioid Pain Patches by Application (2020-2031)
 Figure 63. Global Non-opioid Pain Patches Price (USD/Pcs) by Application (2020-2031)
 Figure 64. Non-opioid Pain Patches Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart